IN8bio, Inc. (INAB)
1.05
+0.06
(+6.50%)
USD |
NASDAQ |
Oct 23, 16:00
1.04
-0.01
(-0.95%)
After-Hours: 20:00
IN8bio EPS Diluted (Quarterly) : -0.2456 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2456 |
| March 31, 2026 | -0.2615 |
| December 31, 2025 | -0.506 |
| September 30, 2025 | -0.8493 |
| June 30, 2025 | -1.237 |
| March 31, 2025 | -0.0665 |
| December 31, 2024 | -2.550 |
| September 30, 2024 | -0.1497 |
| June 30, 2024 | -0.1912 |
| March 31, 2024 | -0.1978 |
| December 31, 2023 | -0.2122 |
| September 30, 2023 | -0.2273 |
| Date | Value |
|---|---|
| June 30, 2023 | -0.271 |
| March 31, 2023 | -0.3042 |
| December 31, 2022 | -0.3177 |
| September 30, 2022 | -0.3416 |
| June 30, 2022 | -0.3813 |
| March 31, 2022 | -0.3268 |
| December 31, 2021 | -0.3114 |
| September 30, 2021 | -0.1808 |
| March 31, 2021 | -0.1586 |
| September 30, 2020 | -0.1127 |
| March 31, 2020 | -0.1008 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.781M |
| Total Expenses (Quarterly) | 4.781M |
| Enterprise Value | -5.433M |
| Earnings Yield | -177.4% |
| Normalized Earnings Yield | -177.37 |